ID: ALA2075020

Max Phase: Preclinical

Molecular Formula: C5H10N2O3

Molecular Weight: 146.15

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CNCC(=O)NCC(=O)O

Standard InChI:  InChI=1S/C5H10N2O3/c1-6-2-4(8)7-3-5(9)10/h6H,2-3H2,1H3,(H,7,8)(H,9,10)

Standard InChI Key:  XBSXVUHHZXULRO-UHFFFAOYSA-N

Associated Targets(non-human)

Solute carrier family 15 member 1 124 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Oligopeptide transporter, kidney isoform 114 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 146.15Molecular Weight (Monoisotopic): 146.0691AlogP: -1.59#Rotatable Bonds: 4
Polar Surface Area: 78.43Molecular Species: ZWITTERIONHBA: 3HBD: 3
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: 3.66CX Basic pKa: 8.80CX LogP: -4.29CX LogD: -4.31
Aromatic Rings: 0Heavy Atoms: 10QED Weighted: 0.45Np Likeness Score: -0.26

References

1. Terada T, Sawada K, Irie M, Saito H, Hashimoto Y, Inui K..  (2000)  Structural requirements for determining the substrate affinity of peptide transporters PEPT1 and PEPT2.,  440  (1): [PMID:11007306] [10.1007/s004240000339]